期刊文献+

TRAIL蛋白与顺铂联合应用对卵巢上皮性癌裸鼠腹腔移植瘤生长的抑制作用 被引量:5

原文传递
导出
摘要 卵巢上皮性癌(卵巢癌)被发现时多为晚期,且治疗效果较差,寻找新的、有效杀灭肿瘤细胞的治疗方法迫在眉睫。肿瘤坏死因子(TNF)相关的凋亡诱导配体(TNF-related apoptosis-inducing ligand,TRAIL)是导致细胞凋亡的重要的细胞因子,TRAIL能选择性地诱导肿瘤细胞凋亡,而对正常组织和细胞没有明显的毒性。本研究建立了人卵巢癌细胞系SKOV3的裸鼠腹腔移植瘤模型,探讨TRAIL蛋白与顺铂(DDP)联合应用对肿瘤生长的抑制作用,以及DDP对TRAIL受体的影响,为TRAIL应用于卵巢癌的生物治疗提供实验依据。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2006年第8期568-569,共2页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献9

  • 1Wiley SR,Schooley K,Smolak PJ,et al.Indentification and characterization of a new member of the TNF family that induces apoptosis.Immunity,1995,3:673-682.
  • 2Ashkenazi A,Pai RC,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clin Invest,1999,104:155-162.
  • 3Abou El Hassan MA,Mastenbroek DC,Gerritsen WR,et al.Overexpression of Bcl2 abrogates chemo-and radiotherapy-induced sensitization of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL.Br J Cancer,2004,91:171-177.
  • 4Gliniak B,Le T.Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.Cancer Res,1999,59:6153-6158.
  • 5Wen J,Ramadevi N,Nguyen D,et al.Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.Blood,2000,96:3900-3906.
  • 6Jin H,Yang R,Fong S,et al.Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.Cancer Res,2004,64:4900-4905.
  • 7Fan QL,Zou WY,Song LH,et al.Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A.549 cell lines in vitro and in vivo.Cancer Chemother Pharmacol,2005,55:189-196.
  • 8Ravi R,Bedi GC,Engstrom LW,et al.Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.Nat Cell Biol,2001,3:409-416.
  • 9Jo M,Kim TH,Seol DW,et al.Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.Nat Med,2000,6:564-567.

同被引文献91

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部